Percutaneous Pulmonary Valve Implantation Based on Minimally Invasive Direct Coronary Bypass Surgery.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 32145193.
- Also identified by DOI 10.1016/j.athoracsur.2020.01.062.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Approximately 5% of percutaneous pulmonary valve implantations (PPVIs) are at risk for coronary compression. Therefore, PPVI is contraindicated if coronary anomalies and tested coronary flow impairment are observed. Simultaneous right ventricular outflow tract ballooning and coronary angiography are mandatory elucidating contraindications for PPVI. We present the case of a 22-year-old woman who had Rastelli repair with chronic right heart failure. Weighing the risk of several offered surgical options, she underwent successful PPVI after minimally invasive direct coronary artery bypass procedure.
Medical subject headings
- Coronary Artery Bypass
- Heart Valve Prosthesis Implantation
- Pulmonary Valve
- Pulmonary Valve Stenosis